Lloyd J. Old: The Pioneering Cancer Immunologist

A Legacy of Discovery and Innovation

Lloyd J. Old is renowned for his groundbreaking contributions to the field of cancer immunology, which have transformed our understanding of the disease and paved the way for the development of innovative treatments. As one of the founders of the field, Old's research has established many of the principles and priorities of modern tumor immunology, earning him international recognition and accolades.

Early Life and Education

Born on September 23, 1933, in San Francisco, California, Old developed an early interest in medicine and science. He earned his undergraduate degree from the University of California, Berkeley, and went on to receive his medical degree from the University of California, San Francisco.

Pioneering Research in Cancer Immunology

Old's research career spanned over five decades, during which he made numerous seminal discoveries that have shaped the field of cancer immunology. Some of his most notable contributions include:

• Introducing bacillus Calmette-Guérin (BCG) to tumor immunotherapy, which has become a cornerstone of cancer treatment
• Discovering the link between the major histocompatibility complex (MHC) and disease, specifically leukemia
• Uncovering the unexpected association between Epstein-Barr virus (EBV) and nasopharyngeal carcinoma
• Defining the concept of cell-surface differentiation antigens with the discovery of TL, Lyt (CD8), and other mouse antigenic systems
• Identifying tumor necrosis factors (TNF) and their role in cancer treatment
• Discovering the tumor immunogenicity of heat shock proteins
• Independently discovering p53, a tumor suppressor gene, along with two other research groups

Leadership and Mentorship

Old's dedication to advancing cancer research extended beyond his own laboratory. He held various leadership positions, including:

• Director of the Ludwig Cancer Research New York Branch (LICR)
• Trustee of the LICR Charitable Trust and the Virginia D.K. Ludwig Fund for Cancer Research
• Founding scientific and medical director of the Cancer Research Institute (CRI)
• Director of the CRI-LICR Cancer Vaccine Collaborative (CVC), an international network dedicated to testing and optimizing therapeutic cancer vaccines

Old was also an esteemed teacher and mentor, guiding numerous young researchers as they began their careers. His passion for education and collaboration has inspired generations of scientists to pursue careers in cancer research.

Awards and Honors

Old's contributions to cancer research have been recognized with numerous awards and honors, including:

• The William B. Coley Award for Distinguished Research in Basic and Tumor Immunology
• The Albert Lasker Clinical Medical Research Award
• The National Medal of Science
• Election to the National Academy of Sciences, the National Academy of Medicine, and the American Academy of Arts and Sciences

Legacy and Impact

Lloyd J. Old's pioneering work has had a profound impact on our understanding of cancer and its treatment. His discoveries have paved the way for the development of innovative immunotherapies, which are revolutionizing cancer care. As a testament to his influence, the field of cancer immunology continues to grow, with researchers building upon Old's foundational work to develop new and effective treatments for this devastating disease.

Personal Milestones and Key Life Events

Throughout his life, Old was driven by a passion for discovery and a commitment to improving human health. He passed away on November 28, 2011, leaving behind a legacy that continues to inspire and motivate cancer researchers worldwide.

In recognition of his extraordinary contributions, the Cancer Research Institute established the Lloyd J. Old Award in 2012, which honors outstanding researchers in the field of cancer immunology.